ORAL-CONTRACEPTIVES AND PLASMA-PROTEIN METABOLISM

被引：14

作者：

BRIGGS, MH ^{[1
]}

BRIGGS, M ^{[1
]}

机构：

[1] GEELONG HOSP,GEELONG,VICTORIA,AUSTRALIA

来源：

关键词：

D O I：

10.1016/0022-4731(79)90062-1

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：425 / 428

页数：4

共 21 条

[1]

ANDERSON D C, 1972, Journal of Endocrinology, V55, pXI

[2]

ANDERSON DW, 1978, LANCET, V1, P819

BRADWELL, AR ;

BURNETT, D ;

RAMSDEN, DB ;

BURR, WA ;

PRINCE, HP ;

HOFFENBERG, R .

[4]

BRIGGS M, 1976, ADV STEROID BIOCHEM, V5, P65

[5]

BRIGGS M. H., 1970, Advances in Steroid Biochemistry and Pharmacology, V2, P111

[6]

BRIGGS MH, 1978, ANNUAL RES REV ORAL, V2, P87

[7]

BRIGGS MH, 1977, ANNUAL RES REV ORAL, P45

[8]

BRIGGS MH, 1978, 6TH P AS OC C END, V1, P114

[9]

BRIGGS MH, 1978, RISKS BENEFITS CONTR, P214

[10]

CROWELL EB, 1971, J LAB CLIN MED, V77, P551